Intratumoral Epiregulin Is a Marker of Advanced Disease in Non–Small Cell Lung Cancer Patients and Confers Invasive Properties on <i>EGFR</i> -Mutant Cells

Jie Zhang(Medical University of South Carolina), Jonathan M. Kurie(The University of Texas MD Anderson Cancer Center)
Cancer Prevention Research
March 31, 2008
Cited by 86


Related Papers